Cellular protein is the source of cross-priming antigen in vivo.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2004-03-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.0308345101PMID 14978273PMCID PMC365740
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitating protein synthesis, degradation, and endogenous antigen processing.

  2003cited by this paper
• ISO: a critical evaluation of the role of peptides in heat shock/chaperone protein-mediated tumor rejection.

  2003cited by this paper
• Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses.

  2002cited by this paper
• Protein degradation and the generation of MHC class I-presented peptides.

  2002cited by this paper
• Transfer of GRP94(Gp96)‐Associated Peptides onto Endosomal MHC Class I Molecules

  2002cited by this paper
• Radicicol-sensitive Peptide Binding to the N-terminal Portion of GRP94*

  2002cited by this paper
• Exosomes: composition, biogenesis and function

  2002cited by this paper
• GRP94 (gp96) and GRP94 N-Terminal Geldanamycin Binding Domain Elicit Tissue Nonrestricted Tumor Suppression

  2002cited by this paper
• Cross-presentation in viral immunity and self-tolerance

  2001cited by this paper
• Anti-Peptide Antibody Blocks Peptide Binding to MHC Class I Molecules in the Endoplasmic Reticulum1

  2001cited by this paper
• CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.

  2001cited by this paper
• Dendritic Cells Acquire Antigens from Live Cells for Cross-Presentation to CTL1

  2001cited by this paper
• Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo1

  2001cited by this paper
• Cross-presentation, dendritic cells, tolerance and immunity.

  2001cited by this paper
• Cross-Presentation of Glycoprotein 96–Associated Antigens on Major Histocompatibility Complex Class I Molecules Requires Receptor-Mediated Endocytosis

  2000cited by this paper
• Receptor-Mediated Uptake of Antigen/Heat Shock Protein Complexes Results in Major Histocompatibility Complex Class I Antigen Presentation via Two Distinct Processing Pathways

  2000cited by this paper
• DNA vaccination: antigen presentation and the induction of immunity

  2000cited by this paper
• Characterization of MHC class II‐presented peptides generated from an antigen targeted to different endocytic compartments

  2000cited by this paper
• Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

  1999cited by this paper
• Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

  1999cited by this paper
• Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells

  1998cited by this paper
• Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

  1998cited by this paper
• Immunization with a Lymphocytic Choriomeningitis Virus Peptide Mixed with Heat Shock Protein 70 Results in Protective Antiviral Immunity and Specific Cytotoxic T Lymphocytes

  1998cited by this paper
• Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide.

  1997cited by this paper
• Processing of engulfed apoptotic bodies yields T cell epitopes.

  1997cited by this paper
• Targeting of HIV-1 Antigens for Rapid Intracellular Degradation Enhances Cytotoxic T Lymphocyte (CTL) Recognition and the Induction of De Novo CTL Responses In Vivo After Immunization

  1997cited by this paper
• Heat Shock Protein–Peptide Complexes, Reconstituted In Vitro, Elicit Peptide-specific Cytotoxic T Lymphocyte Response and Tumor Immunity

  1997cited by this paper
• Capture and processing of exogenous antigens for presentation on MHC molecules.

  1997cited by this paper
• Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.

  1997cited by this paper
• Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody.

  1997cited by this paper
• ER quality control: the cytoplasmic connection.

  1997cited by this paper
• A comparison of the immunogenicity of the native and denatured forms of a protein

  1996cited by this paper
• A new foreign policy: MHC class I molecules monitor the outside world.

  1996cited by this paper
• Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity

  1995cited by this paper
• A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.

  1995cited by this paper
• Differential ability of isolated H-2 Kb subsets to serve as TCR ligands for allo-specific CTL clones: potential role for N-linked glycosylation

  1995cited by this paper
• Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines

  1994cited by this paper
• Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

  1994cited by this paper
• Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.

  1993cited by this paper
• Generation of class I MHC-restricted T-T hybridomas.

  1990cited by this paper
• Peptide binding and release by proteins implicated as catalysts of protein assembly.

  1989cited by this paper

• Alternate MHC I antigen presentation pathways allow CD8+ T-cell recognition and killing of cancer cells in the absence of ß2M or TAP.

  2024cites this paper
• Vaccine adjuvants: Tailoring innate recognition to send the right message.

  2024cites this paper
• Peptide‐Driven Proton Sponge Nano‐Assembly for Imaging and Triggering Lysosome‐Regulated Immunogenic Cancer Cell Death

  2024cites this paper
• Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion

  2024cites this paper
• Challenges in developing personalized neoantigen cancer vaccines

  2023cites this paper
• Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross‐priming

  2023cites this paper
• Calpains Released from Necrotic Tumor Cells Enhance Antigen Cross-Presentation to Activate CD8+ T Cells In Vitro

  2022cites this paper
• Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation

  2021cites this paper
• The Origin and Immune Recognition of Tumor-Specific Antigens

  2020cites this paper
• Evidence for an involvement of the ubiquitin‐like modifier ISG15 in MHC class I antigen presentation

  2020cites this paper
• Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells

  2020cites this paper
• Peptide Channeling: The Key to MHC Class I Immunosurveillance?

  2019cites this paper
• Enhanced immunogenicity of mitochondrial localised proteins in cancer cells

  2019cites this paper
• Modified Vaccinia Virus Ankara Can Induce Optimal CD8+ T Cell Responses to Directly Primed Antigens Depending on Vaccine Design

  2019cites this paper
• DNA vaccination for finfish aquaculture.

  2019cites this paper
• Polyglutamine-related aggregates serve as a potent antigen source for cross presentation by dendritic cells

  2019cites this paper
• The GTPase Rab39a promotes phagosome maturation into MHC‐I antigen‐presenting compartments

  2019cites this paper
• Cross-priming induces immunodomination in the presence of viral MHC class I inhibition

  2018cites this paper
• Viral MHC Class I Evasion Affects Anti-viral T Cell Development and Responses

  2018cites this paper
• The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules.

  2017cites this paper
• DNA nanotechnology-based composite-type gold nanoparticle-immunostimulatory DNA hydrogel for tumor photothermal immunotherapy.

  2017cites this paper
• HSPs - Ambiguous Mediators of Immunity

  2017cites this paper
• Identification and Characterization of Rab39a and Its Role in Crosspresentation

  2017cites this paper
• Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6

  2017cites this paper
• Functional Specialization of Dendritic Cell Subsets

  2016cites this paper
• Spatiotemporal Regulation of Hsp90–Ligand Complex Leads to Immune Activation

  2016cites this paper
• The effect of tumour antigen properties on the efficiency of cross-presentation

  2016influential citation
• Regulatory role of heat-shock proteins in autoimmune and inflammatory diseases

  2016cites this paper
• Vector delivery-dependant effect of human tissue plasminogen activator signal peptide on vaccine induction of T cells

  2016cites this paper
• Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets

  2015cites this paper
• Immune Control of Cytomegalovirus in the Salivary Glands

  2015cites this paper
• A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice

  2015cites this paper
• The Cross-Priming Capacity and Direct Presentation Potential of an Autoantigen Are Separable and Inversely Related Properties

  2014cites this paper
• Separable and Inversely Related Properties Presentation Potential of an Autoantigen Are The Cross-Priming Capacity and Direct

  2014cites this paper
• Chemotherapy Enhances Cross-Presentation of Nuclear Tumor Antigens

  2014cites this paper
• Salivary gland resident APCs are Flt3L‐ and CCR2‐independent macrophage‐like cells incapable of cross‐presentation

  2014cites this paper
• Immunogenicity of necrotic cell death

  2014cites this paper
• GP96 Interacts with HHV-6 during Viral Entry and Directs It for Cellular Degradation

  2014cites this paper
• Optimal conditions required for influenza A infection‐enhanced cross‐priming of CD8+ T cells specific to cell‐associated antigens

  2013cites this paper
• VaccinesInduced by Canarypox Virus Characterization of Antigen-Specific Immune

  2013cites this paper
• Anti-Nucleic Acid Antibody-Mediated Cross Presentation of An Antigen and Its CD8+ T Cell Activation

  2013cites this paper
• Etude de l’efficacité et des mécanismes de la présentation croisée d’antigènes cellulaires tumoraux intacts par les cellules dendritiques

  2013cites this paper
• Exosome release from infected dendritic cells: a clue for a fast spread of prions in the periphery?

  2013cites this paper
• immune responses in vivo Cross-presentation by dendritic cells from live cells induces protective

  2013cites this paper
• The role of dendritic cells in adjuvant-induced immune responses

  2013cites this paper
• Stable Antigen Is Most Effective for Eliciting CD8+ T-Cell Responses after DNA Vaccination and Infection with Recombinant Vaccinia Virus In Vivo

  2012cites this paper
• DNA and Modified Vaccinia Virus Ankara Vaccines Encoding Multiple Cytotoxic and Helper T-Lymphocyte Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) Are Safe but Weakly Immunogenic in HIV-1-Uninfected, Vaccinia Virus-Naive Adults

  2012cites this paper
• Identification of novel HLA-A*0201-restricted epitopes from anterior gradient-2 as a tumor-associated antigen against colorectal cancer

  2012cites this paper
• Development and Characterization of a novel Immunotherapy against Prostate Cancer

  2012cites this paper
• INTEGRATION OF HSP90 INHIBITION IN COMBINATIONAL IMMUNOTHERAPIES TARGETING RECEPTOR TYROSINE KINASE EPHA2

  2012cites this paper
• On the Source of Peptides for Major Histocompatibility Class I Antigen Presentation: A Dissertation

  2012cites this paper
• The direction of protein entry into the proteasome determines the variety of products and depends on the force needed to unfold its two termini.

  2012cites this paper
• A Polymeric Protein Induces Specific Cytotoxicity in a TLR4 Dependent Manner in the Absence of Adjuvants

  2012cites this paper
• Abscopal Effect of Radiation Therapy: Current Concepts and Future Applications

  2012cites this paper
• Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice.

  2012cites this paper
• Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation.

  2012cites this paper
• The Role of Heat Shock Proteins in Antigen Cross Presentation

  2012cites this paper
• Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors

  2011cites this paper
• The subcellular location of antigen expressed by adenoviral vectors modifies adaptive immunity but not dependency on cross‐presenting dendritic cells

  2011cites this paper
• The role of antigen cross-presentation in the vaccine-induced activation of cytotoxic T-lymphocytes

  2011cites this paper
• Antigen Presentation Ability of Salmonella Carrying DNA Vaccine Model and MCP-3 gene

  2011cites this paper
• Cell-Mediated Tumor Immunity Antigen Localization Controls T

  2011influential citation
• Regulation of memory CD8 T cell differentiation

  2011cites this paper
• Antigen Localization Controls T Cell-Mediated Tumor Immunity

  2011influential citation
• Dendritic Cells Crosspresent Antigens from Live B16 Cells More Efficiently than from Apoptotic Cells and Protect from Melanoma in a Therapeutic Model

  2011cites this paper
• Comparative study of using different yeast genera as vehicles for protein delivery to antigen-presenting cells

  2011cites this paper
• Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism

  2011cites this paper
• Correction: Efficient Cross-Priming of Antiviral CD8+ T Cells by Antigen Donor Cells Is GRP94 Independent

  2010cites this paper
• Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo.

  2010cites this paper
• Nonsense Mediated Decay Resistant Mutations Are a Source of Expressed Mutant Proteins in Colon Cancer Cell Lines with Microsatellite Instability

  2010cites this paper
• a TLR7- and Type I IFN-Dependent Fashion T Cells to Cell-Associated Antigens in + of CD8 Influenza A Infection Enhances Cross-Priming

  2010cites this paper
• Influenza A Infection Enhances Cross-Priming of CD8+ T Cells to Cell-Associated Antigens in a TLR7- and Type I IFN-Dependent Fashion

  2010influential citation
• Synthetic pathogens for integrated biophysical and genetic dissection of antigen cross-presentation

  2010cites this paper
• Identification of potential HLA class I and class II epitope precursors associated with heat shock protein 70 (HSPA)

  2010cites this paper
• dans l'activation des lymphocytes T Natural Killer invariants

  2010cites this paper
• MHC-I-restricted HIV epitope processing, immune control and immunogen design

  2010cites this paper
• Direct antigen presentation by DC shapes the functional CD8+ T‐cell repertoire against the nuclear self‐antigen La‐SSB

  2010cites this paper
• ANALYSIS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS ANTIGENS PRESENTATION BY MACROPHAGES

  2010cites this paper
• Type I IFN-Dependent Fashion Cell-Associated Antigens in a TLR7- and T Cells to + Cross-Priming of CD8 Influenza A Infection Enhances

  2010influential citation
• Long peptides induce polyfunctional T cells against conserved regions of HIV‐1 with superior breadth to single‐gene vaccines in macaques

  2010cites this paper
• Designing CD8+ T cell vaccines: it's not rocket science (yet).

  2010cites this paper
• Transcriptomic biomarkers of human ageing in peripheral blood mononuclear cell total RNA.

  2010cites this paper
• The pathogenicity of self-antigen decreases at high levels of autoantigenicity: a computational approach.

  2010cites this paper
• Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses

  2010cites this paper
• Efficient Cross-Priming of Antiviral CD8+ T Cells by Antigen Donor Cells Is GRP94 Independent1

  2009cites this paper
• DEVELOPING COMBINATIONAL IMMUNOTHERAPIES TARGETING TUMOR RECEPTOR TYROSINE KINASES

  2009cites this paper
• Receptor-Mediated Antigen Delivery by Α 2 -Macroglobulin: Effect on Cytotoxic T Lymphocyte Immunity and Implications for Vaccine Development

  2009cites this paper
• Heat shock proteins in antigen trafficking–Implications on antigen presentation to T cells

  2009cites this paper
• Identification and modification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from Ran antigen

  2009cites this paper
• MHC ligand generation in T cell-mediated immunity and MHC multimer technologies for T cell detection

  2009cites this paper
• Is GRP94 Independent T Cells by Antigen Donor Cells + CD8Cross-Priming of Antiviral

  2009cites this paper
• Independent T Cells by Antigen Donor Cells + CD 8 Efficient Cross-Priming of Antiviral

  2009cites this paper
• Antigen processing and presentation: Contributions of the cross-presentation pathway in eliciting CD8+ T cell responses in vivo

  2009cites this paper
• Induction of protective cytotoxic T cell responses by a B cell-based cellular vaccine requires stable expression of antigen

  2009cites this paper
• CTL induction by cross‐priming is restricted to immunodominant epitopes

  2009cites this paper
• Viral Sequestration of Antigen Subverts Cross Presentation to CD8+ T Cells

  2009influential citation
• Efficient cross-presentation depends on autophagy in tumor cells.

  2008cites this paper
• Distinct binding sites for the ATPase and substrate-binding domain of human Hsp70 on the cell surface of antigen presenting cells.

  2008cites this paper
• Antigens for cancer immunotherapy.

  2008cites this paper
• The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation.

  2008cites this paper